BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $668,600 | +23.9% | 94,435 | +23.2% | 0.01% | +16.7% |
| Q2 2023 | $539,700 | -53.9% | 76,662 | -17.5% | 0.01% | -76.0% |
| Q3 2022 | $1,170,000 | +358.8% | 92,879 | +286.0% | 0.02% | +257.1% |
| Q2 2022 | $255,000 | -86.5% | 24,061 | -81.6% | 0.01% | -77.4% |
| Q3 2021 | $1,883,000 | +89.4% | 131,066 | +108.4% | 0.03% | +63.2% |
| Q2 2021 | $994,000 | +68.8% | 62,898 | +8.6% | 0.02% | +58.3% |
| Q1 2021 | $589,000 | +501.0% | 57,917 | +18.0% | 0.01% | +33.3% |
| Q1 2020 | $98,000 | -81.4% | 49,102 | -67.9% | 0.01% | -62.5% |
| Q4 2019 | $528,000 | +212.4% | 153,107 | +158.9% | 0.02% | +300.0% |
| Q3 2019 | $169,000 | +20.7% | 59,148 | +60.4% | 0.01% | +50.0% |
| Q2 2019 | $140,000 | -73.9% | 36,867 | -64.0% | 0.00% | -71.4% |
| Q3 2017 | $537,000 | +130.5% | 102,494 | +144.5% | 0.01% | +100.0% |
| Q2 2017 | $233,000 | +375.5% | 41,928 | +276.5% | 0.01% | +600.0% |
| Q3 2016 | $49,000 | +4.3% | 11,137 | -33.3% | 0.00% | 0.0% |
| Q2 2016 | $47,000 | -86.8% | 16,687 | -86.7% | 0.00% | -88.9% |
| Q1 2016 | $355,000 | +208.7% | 125,588 | +1022.8% | 0.01% | +200.0% |
| Q4 2015 | $115,000 | -65.9% | 11,185 | -62.1% | 0.00% | -72.7% |
| Q3 2015 | $337,000 | +69.3% | 29,535 | +121.9% | 0.01% | +83.3% |
| Q2 2015 | $199,000 | – | 13,308 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
| Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
| Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
| Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
| DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
| KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
| Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
| ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
| Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |